- Notes on the Contributors
- List of Abbreviations
- Brain Reading: Decoding Mental States From Brain Activity In Humans
- The Neurobiology of Pleasure and Happiness
- The Neurobiological Basis of Morality
- Development of the Adolescent Brain: Neuroethical Implications for the Understanding of Executive Function and Social Cognition
- Neural Foundations to Conscious and Volitional Control of Emotional Behavior: A Mentalistic Perspective
- Neural Correlates of Deception
- Understanding Disorders of Consciousness
- Functional Magnetic Resonance Imaging, Covert Awareness, and Brain Injury
- Genetic Determinism, Neuronal Determinism, and Determinism <i>Tout Court</i>
- The Rise of Neuroessentialism
- A Neuroscientific Approach to Addiction: Ethical Concerns
- The Neurobiology of Addiction: Implications for Voluntary Control of Behavior
- Neuroethics of Free Will
- Pharmaceutical Cognitive Enhancement
- Cognitive Enhancement
- Chemical Cognitive Enhancement: Is it Unfair, Unjust, Discriminatory, or Cheating for Healthy Adults to Use Smart Drugs?
- Cognitive Enhancement in Courts
- Neuroethics and the Extended Mind
- Does Cognitive Enhancement Fit with the Physiology of Our Cognition?
- Attention Deficit Hyperactivity Disorder: Defining A Spectrum Disorder and Considering Neuroethical Implications
- Why Neuroethicists are Needed
- Intersecting Complexities in Neuroimaging and Neuroethics
- Pediatric Neuroimaging Research
- Ethical Issues in Functional Neurosurgery: Emerging Applications and Controversies
- Non-Invasive Brain Stimulation As A Therapeutic And Investigative Tool: An Ethical Appraisal
- Deep Brain Stimulation For Treatment-Resistant Neuropsychiatric Disorders
- The Ethical Issues of Trials of Neural Grafting in Patients with Neurodegenerative Conditions
- The Ethics Of Nano/Neuro Convergence
- Neurobiological And Neuroethical Perspectives On The Contribution Of Functional Neuroimaging To The Study Of Aging In The Brain
- Clinical Research On Conditions Affecting Cognitive Capacity
- Ethical Concerns And Pitfalls In Neurogenetic Testing
- Neuroethical Issues In Early Detection Of Alzheimer’S Disease
- the neuroethics of cognitive reserve
- Ethical Issues In The Management Of Parkinson’S Disease
- The Other Ethical Challenge of Neurodegenerative Diseases
- Future Scoping: Ethical Issues In Aging And Dementia
- Incidental Findings In Neuroscience Research: A Fundamental Challenge To The Structure Of Bioethics And Health Law
- What Will Be the Limits of Neuroscience-based Mindreading in the Law?
- For The Law, Neuroscience Changes Nothing And Everything
- New Directions In Neuroscience Policy
- Women’s Neuroethics
- Public Representations Of Neurogenetics
- Brain Trust: Neuroscience and national security in the 21st century
- Neuroplasticity, Culture, and Society
- Neuroscience and neuroethics in the 21st century
- Neuroscience and the media: ethical challenges and opportunities
- Ethical issues in Educational Neuroscience: Raising children in a Brave New World
- From The Internationalization To The Globalization Of Neuroethics: Some Perspectives And Challenges
- Global Health Ethics
- Ethical Perspectives: Clinical Drug Trials In Developing Countries
- Learning About Neuroethics Through Health Sciences Online: A Model For Global Dissemination
- Neuroethics And The Lure of Technology
- Subject Index
- Author Index
Abstract and Keywords
Prospective follow-up studies have shown that even though some children outgrow the disorder, a childhood diagnosis of attention deficit hyperactivity disorder (ADHD) is clearly a risk factor for a broad range of adverse outcomes, with extremes including drug abuse and juvenile delinquency. This article considers the use of several spectrum concepts and some neuroethical issues. It provides a list of criterion symptoms with a threshold set for the number of symptoms required for categorical diagnoses of disorders. It gives a brief review of some brain imaging and pharmacological treatment studies of ADHD to set the stage for a consideration of brain-specific issues related to neuroethics. Studies using reaction time (RT) tasks of cognitive control, response inhibition, and conflict have identified interindividual variance in task performance as one of the most prominent aspects of cognitive deficits related to ADHD.
James M. Swanson served as the initial Principal Investigator at UC Irvine for two multisite treatment studies of ADHD (the MTA and PATS), for several clinical trials for the development of new medications for ADHD, and currently for the Orange County CA Vanguard Center of the National Children’s Study.
Timothy Wigal is an Adjunct Professor of Pediatrics and Director of the University of California Irvine, Child Development Center and is the principal investigator of the Multimodal Treatment study of Children with Attention Deficit Hyperactivity Disorder (ADHD). He is a licensed psychologist with expertise in diagnosis and treatment of ADHD in children and adults.
Kimberley Lakes is an Assistant Professor in the Department of Pediatrics at the University of California, Irvine. She received her Ph.D from the University of Wisconsin, Madison and completed a postdoctoral fellowship at the Children’s Hospital of Orange County and UC Irvine. Dr. Lakes is an elected member of the Society of Pediatric Research.
Nora D. Volkow became Director of the National Institute on Drug Abuse (NIDA) in May 2003. Her pioneering use of brain imaging to investigate the toxic effects and addictive properties of drugs was instrumental in demonstrating that drug addiction is a disease of the brain.
Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.